Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials
Crossref DOI link: https://doi.org/10.1007/s13300-016-0153-3
Published Online: 2016-02-10
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hanefeld, Markolf
Monnier, Louis
Schnell, Oliver
Owens, David
Funding for this research was provided by:
Sanofi
Text and Data Mining valid from 2016-02-10
Article History
Received: 10 November 2015
First Online: 10 February 2016